Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: Is postradiotherapy neck dissection necessary?

Radiation Oncology Investigations

Volumn 6, Issue 1, 1998, Pages 52-57

  Johnson, Christopher R ^a   Silverman, Larry N ^b   Clay, Louise B ^b   Schmidt Ullrich, Rupert ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Combined modality; Concomitant boost; Fractionation; Head and neck neoplasms; Neck dissection; Observation; Radiotherapy; Response

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CERVICAL LYMPH NODE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; TREATMENT OUTCOME;

EID: 0031892658     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1998)6:1<52::AID-ROI6>3.0.CO;2-H     Document Type: Article

References (20)

1. Fletcher GH: The third annual lectureship of the Juan Del Regato Foundation: Squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 5:2075-2090, 1979.
2. Mendenhall WM, Million RR, Cassisi NJ: Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12: 733-740, 1986.
3. Barkley HT, Fletcher GH, Jessee RH, Lindberg RD: Management of cervical lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 124:462-467, 1972.
4. Mendenhall WM, Parsons JT, Amdur RJ, Cassisi NJ, Million RR: Squamous cell carcinoma of the head and neck treated with radiotherapy: Does planned neck dissection reduce the chance for successful surgical management of subsequent local recurrence? Head Neck Surg 10:302-304, 1988.
5. Levendag P, Sessions R, Vikram B, Strong E, Shah J, Spiro R, Gerold F: The problem of neck relapse in early stage supraglottic larynx cancer. Cancer 63:345-348, 1989.
6. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR: Squamous cell carcinoma of the head and neck treated with irradiation: Management of the neck. Sem Rad One 2:163-170, 1992.
7. Parsons JT, Vikram B: Letters to the editor: Elective postoperative radiation therapy following supraglottic laryngectomy: A simple new technique. Radiat Oncol Invest 243-245, 1996.
8. Bataini JP, Bernier J, Jaulerry C, Brunin F, Pontvert D, Lave C: Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy. Int J Radiat Oncol Biol Phys 13: 817-824, 1987.
9. Bernier J, Bataini JP: Regional outcome in oropharyngeal and laryngopharyngeal cancer treated with high dose per fraction radiotherapy: Analysis of neck disease response in 1646 cases. Radiother Oncol 6:87-103, 1986.
10. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS, Goepfert H: The role of neck surgery in patients with oropharyngeal cancer treated by radiotherapy. Int J Radiat Oncol Biol Phys 36, Supp 1:164, 1996.
11. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS, Goepfert H: Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head and Neck 18:552-559, 1996.
12. Schmidt-Ullrich RK, Johnson CR, Wazer DE, Masko G, Chasin WD, Karmody CS: Accelerated superfractionated irradiation for advanced carcinoma of the head and neck: Concomitant boost technique. Int J Radiat Oncol Biol Phys 21:563-568, 1991.
13. Johnson CR, Schmidt-Ullrich RK, Wazer DE: Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. Cancer 69:2749-2754, 1992.
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assn 53:457-481, 1958.
15. Mantel N, Haenzel W: Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 22: 719-748, 1959.
16. Mak AC, Morrison WH, Garden AS, Ang KK, Goepfert H, Peters LJ: Base of tongue carcinoma: treatment results using concomitant boost radiotherapy. Int J Radiat Oncol Biol Phys 33:289-296, 1995.
17. Barkley HT, Fletcher GH: The significance of residual disease after external irradiation of squamous cell carcinoma of the oropharynx. Radiology 124:493-495, 1977.
18. Bartelink H: Prognostic value of the regression rate of neck node metastases during radiotherapy. Int J Radiat Oncol Biol Phys 9:993-996, 1983.
19. Maciewejski B: Regression rate of metastatic lymph nodes after radiation treatment as a prognostic factor for local control. Radiother Oncol 4:301-308, 1987.
20. Inoue T, Matayoshi Y, Inoue T, Ikeda H, Teshima T, Murayama S: Prognostic factors in telecobalt therapy for early supraglottic carcinoma. Cancer 72:57-61, 1993.